Arthur Becker
Fondateur chez Atlantic Investors LLC
Provenance du réseau au premier degré de Arthur Becker
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information.
134
| Extinct | Investment Banks/Brokers | 134 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.
18
| Holding Company | Biotechnology | 18 |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.
9
| Holding Company | Biotechnology | 9 |
ClearBlue Technologies, Inc.
 ClearBlue Technologies, Inc. Information Technology ServicesTechnology Services Clearblue Technologies, Inc. provides data management and storage services. It provides an integrated suite of hosting, information technology, security, and professional services. The company was founded by Andrew Ruhan and is headquartered in San Francisco, CA
1
| Private Company | Information Technology Services | 1 |
Impower Plc
1
| Private Company | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Arthur Becker via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| FEDERAL HOME LOAN MORTGAGE CORPORATION | Finance/Rental/Leasing | Director/Board Member Corporate Officer/Principal | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity Analyst-Equity | |
R. W. Pressprich & Co.
 R. W. Pressprich & Co. Investment Banks/BrokersFinance R. W. Pressprich & Co. (RWP) is an employee-owned institutional broker-dealer headquartered in New York City. Founded in 1909, RWP’s principal focus is to provide fixed-income relative value and market timing research for clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Fixed Income | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Banks/Brokers | Corporate Officer/Principal Director of Research - Equity Corporate Officer/Principal | |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Investment Managers | Chairman Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Doctorate Degree Doctorate Degree Masters Business Admin | |
| Dartmouth College | College/University | Undergraduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| Syracuse University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree | |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| C4 THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member Founder Director/Board Member | |
| New York University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
Mana Therapeutics, Inc.
 Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member Director/Board Member | |
| The University of Colorado | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| The State University of New York | College/University | Undergraduate Degree Chairman Undergraduate Degree Undergraduate Degree | |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
| Microbial Machines, Inc. | Director/Board Member Chief Executive Officer Founder | ||
| Raqia Therapeutics, Inc. | Chairman Director/Board Member Director/Board Member | ||
Bublup, Inc.
 Bublup, Inc. Internet Software/ServicesTechnology Services Bublup, Inc. engages in the development of a cloud platform for saving photos and documents. The company was founded on December 27, 2011 and is headquartered in Arlington, VA. | Internet Software/Services | Chief Executive Officer Chief Executive Officer | |
Regenacy Pharmaceuticals LLC
 Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Apollo European Principal Finance Fund LP | Investment Managers | Chief Investment Officer Founder | |
Kidder, Peabody & Co., Inc.
 Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Graduate Degree Masters Business Admin | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Lightchain Capital LLC
 Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Internet Software/Services | Corporate Officer/Principal Private Equity Investor |
Statistiques
Internationale
| Etats-Unis | 46 |
| Israël | 2 |
| Royaume-Uni | 2 |
| France | 2 |
Sectorielle
| Consumer Services | 18 |
| Finance | 17 |
| Health Technology | 8 |
| Technology Services | 4 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 371 |
| Corporate Officer/Principal | 251 |
| Independent Dir/Board Member | 85 |
| Undergraduate Degree | 78 |
| Founder | 75 |
Relations les plus connectées
| Insiders | |
|---|---|
| Frederic Salerno | 42 |
| Bobby Sandage | 29 |
| Scott Marden | 29 |
| Aida Alvarez | 27 |
| Ronald Suber | 26 |
| Elaine Heron | 23 |
| Gal Israely | 21 |
| Marc A. Cohen | 21 |
| Michael Maselli | 21 |
| Ching Wang | 21 |
| Keith Lough | 21 |
| Thomas O'Neill | 20 |
| William McKee | 20 |
| James Frederic Haft | 20 |
| David Abrams | 19 |
- Bourse
- Insiders
- Arthur Becker
- Connexions Sociétés